Ayrton Drugs
 | |
| GSE: AYRTN | |
| Industry | Pharmaceuticals |
| Founded | September 24, 1965 |
| Headquarters | |
Key people | Chairman- Nik Amarteifio, CEO- Daniel Apeagyei Kissi |
| Products | Teedar, Samalin Cough syrup, Virol blood tonic, Ayrton Para caplets |
| Website | https://ayrtondrug.com (archived) |
Ayrton Drug Manufacturing Limited was a Ghanaian pharmaceutical company. It was established on September 24, 1965. The business entity was listed on the stock index of the Ghana Stock Exchange, the GSE All-Share Index. The factory it ran is based in Tesano, a suburb of Accra. The company's product portfolio included anti-hypertensives, hematinics, dermatological preparations, antibiotics, dewormers, pain killers and anti-inflammatory drugs. In February 2010 Adcock Ingram, a South African pharmaceutical company acquired 66% shares in the company.[1]
In January 2020, Ayrton Drug Manufacturing Limited and two other domestic pharmaceutical companies, Dannex Limited and Starwin Products Limited, had already merged and listed on the GSE as DAS Pharma.[2]
References[edit]
- ^ "Ayrton Drugs Manufacturing Ltd". www.ghanastocks.net. Archived from the original on 23 June 2015. Retrieved 23 June 2015.
- ^ Bruce, Emmanuel (16 January 2020). "Three local pharmaceutical companies merge lists on GSE as DAS Pharma. Three local pharmaceutical companies, Dannex Limited, Ayrton Drug Manufacturing Limited and Starwin Products Limited have merged and listed on the Ghana Stock Exchange as DAS Pharma". Graphic Online. Graphic Communications Group Ltd. Retrieved 6 December 2020.
External links[edit]
- DAS Pharma official homepage
- GhanaWeb.com
- Ayrton Drugs at Alacrastore
- Ayrton Drugs Stock Quote at Ghanastocks.net Archived 2015-06-26 at the Wayback Machine
 | This Ghana-related article is a stub. You can help Wikipedia by expanding it. |
 | This African corporation or company article is a stub. You can help Wikipedia by expanding it. |